Zenas Biopharma, INC. (ZBIO) — SC 13D Filings
All SC 13D filings from Zenas Biopharma, INC.. Browse 2 Activist Stake Filing reports with AI-powered summaries and risk analysis.
SC 13D Filings (2)
-
Longitude Capital Discloses Stake in Zenas BioPharma
— Sep 23, 2024 Risk: medium
On September 23, 2024, Longitude Capital Partners IV, LLC, along with related entities and individuals including Juliet Tammenoms Bakker and Patrick G. Enright, -
Enavate Sciences Files SC 13D for Zenas BioPharma
— Sep 23, 2024 Risk: medium
On September 23, 2024, Enavate Sciences GP, LLC, through Zebra Aggregator, LP, filed an SC 13D, indicating a change in beneficial ownership of Zenas BioPharma,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX